You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sipuleucel-T

Showing 1 - 25 of 8,010
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Testosterone Cypionate
  • Sipuleucel-T
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Sipuleucel-T
  • Stereotactic Ablative Body Radiation
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Prostate Cancer Trial in San Francisco, Houston (SipT Treatment, Ipilimumab)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +1 more
Jul 19, 2021

Prostate Cancer Metastatic Trial in Duarte, Marina Del Rey, Honolulu (Atezolizumab1200 mg IV, Sipuleucel-T)

Completed
  • Prostate Cancer Metastatic
  • Atezolizumab1200 mg IV
  • Sipuleucel-T
  • Duarte, California
  • +2 more
May 24, 2021

Prostate Cancer Trial in Madison (sipuleucel-T, DNA Vaccine)

Completed
Has Results
  • Prostate Cancer
  • sipuleucel-T
  • DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jun 15, 2021

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Radiation Therapy
  • Buffalo, New York
  • +1 more
Aug 4, 2021

Prostate Cancer Recurrent Trial in Indianapolis (Low protein diet, Control protein diet)

Completed
  • Prostate Cancer Recurrent
  • Low protein diet
  • Control protein diet
  • Indianapolis, Indiana
  • +1 more
Mar 25, 2021

Metastatic Castrate-Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Dec 22, 2020

Adenocarcinoma of the Prostate Trial in United States (sipuleucel-T)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • sipuleucel-T
  • Gilbert, Arizona
  • +55 more
Jan 18, 2022

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Metastatic Prostate Cancer Trial in United States (Indoximod, Sipuleucel-T, Placebo)

Completed
Has Results
  • Metastatic Prostate Cancer
  • Indoximod
  • +2 more
  • Chicago, Illinois
  • +3 more
Mar 20, 2020

Prostate Cancer Trial in Durham (Sipuleucel-T, Lymph Node Biopsy)

Completed
  • Prostate Cancer
  • Sipuleucel-T
  • Lymph Node Biopsy
  • Durham, North Carolina
    Duke University Medical Center
Mar 30, 2020

Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)

Terminated
Has Results
  • Prostatic Neoplasms
  • CT-011 (Anti-PD1 Antibody)
  • +2 more
  • Augusta, Georgia
    Georgia Regents University
Jun 18, 2019

Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Terminated
Has Results
  • Prostate Cancer
  • Sipuleucel-T
  • Scottsdale, Arizona
  • +38 more
Jul 16, 2019

Enrolling Advanced Prostate Cancer Who Are to Receive

Completed
  • Castrate Refractory Metastatic Prostate Cancer (mCRPC)
  • Scottsdale, Arizona
    21st Century Oncology
Jan 8, 2019

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer, Castration-resistant Prostate Cancer Trial in United States

Completed
Has Results
  • Prostate Cancer Metastatic
  • +2 more
  • sipuleucel-T
  • abiraterone acetate
  • La Jolla, California
  • +20 more
Mar 5, 2019

Prostate Cancer Trial in New York (Cancer Macrobead placement in abdominal cavity)

Completed
Has Results
  • Prostate Cancer
  • Cancer Macrobead placement in abdominal cavity
  • New York, New York
    The Rogosin Institute
Jan 7, 2019

Metastatic Prostate Cancer in Brazilian Population - Analysis of

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
    • Porto Alegre, RS, Brazil
    • +7 more
    Jun 24, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

    Terminated
    Has Results
    • Metastatic Castration-resistant Prostate Cancer
    • Avelumab
    • 2nd generation ADT (abiraterone or enzalutamide)
    • New Orleans, Louisiana
      Tulane University School of Medicine
    Apr 6, 2022

    Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

    Completed
    • Prostate Cancer
    • Intratumoral (IT) Poly ICLC 0.5 mg
    • +3 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Sep 8, 2022